TScan Therapeutics (TCRX) EPS (Basic) (2020 - 2026)
TScan Therapeutics' (TCRX) quarterly EPS (Basic) came in at -$0.23 in Q2 2026, up 17.98% year-over-year from -$0.2 in Q2 2025, and down 5.88% quarter-over-quarter from -$0.22 in Q1 2026.
Powered by 
Analysis
TScan Therapeutics (TCRX) EPS (Basic) (2020 - 2026) Analysis & Trends
TScan Therapeutics (TCRX) has reported EPS (Basic) for 7 consecutive years, with -$0.23 the latest figure, recorded in Q2 2026.
- On a quarterly basis, EPS (Basic) rose 17.98% year-over-year to -$0.23 in Q2 2026; TTM through Jun 2026 was -$0.91, a 13.39% increase from a year earlier, with the FY2025 full-year figure at -$1.0, up 11.41% from the prior year.
- EPS (Basic) was -$0.23 for Q2 2026 at TScan Therapeutics, down from -$0.22 in the prior quarter.
- Over five years, EPS (Basic) peaked at -$0.18 in Q4 2025 and troughed at -$0.93 in Q1 2023.
- A 5-year average of -$0.41 and a median of -$0.29 in 2023 frame the typical range for EPS (Basic).
- Across the five-year window, EPS (Basic) jumped 91.84% in 2022 and slumped 38.21% in 2023, its largest moves.
- Over 5 years, EPS (Basic) stood at -$0.78 in 2022, then surged by 61.6% to -$0.3 in 2023, then fell by 3.69% to -$0.31 in 2024, then surged by 42.89% to -$0.18 in 2025, then slumped by 31.95% to -$0.23 in 2026.
- The last three EPS (Basic) figures came in at -$0.23 (Q2 2026), -$0.22 (Q1 2026), and -$0.18 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.27 Bn | 9.43 Bn | 112.79 Mn | 1.85 |
| 2 | CRISPR Therapeutics AG | 5.17 Bn | 5.17 Bn | - | -0.94 |
| 3 | Iovance Biotherapeutics | 3.79 Bn | 3.49 Bn | 55.72 Mn | -0.11 |
| 4 | Legend Biotech | 3.68 Bn | 2.71 Bn | 251.50 Mn | 0.42 |
| 5 | uniQure | 3.05 Bn | 3.05 Bn | 5.49 Mn | -1.22 |
| 6 | Beam Therapeutics | 2.65 Bn | 2.65 Bn | - | -1.18 |
| 7 | Precigen | 2.44 Bn | 2.44 Bn | 52.17 Mn | 0.06 |
| 8 | Sarepta Therapeutics | 2.33 Bn | 1.53 Bn | 251.87 Mn | -0.05 |
| 9 | Vericel | 1.99 Bn | 1.83 Bn | 56.40 Mn | 0.04 |
| 10 | TScan Therapeutics | 42.91 Mn | 42.91 Mn | - | -0.23 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -0.23 |
| Mar 31, 2026 | -0.22 |
| Dec 31, 2025 | -0.18 |
| Sep 30, 2025 | -0.28 |
| Jun 30, 2025 | -0.28 |
| Mar 31, 2025 | -0.26 |
| Dec 31, 2024 | -0.31 |
| Sep 30, 2024 | -0.25 |
| Jun 30, 2024 | -0.28 |
| Mar 31, 2024 | -0.32 |
| Dec 31, 2023 | -0.30 |
| Sep 30, 2023 | -0.24 |
| Jun 30, 2023 | -0.51 |
| Mar 31, 2023 | -0.93 |
| Dec 31, 2022 | -0.78 |
| Sep 30, 2022 | -0.67 |
| Jun 30, 2022 | -0.63 |
| Mar 31, 2022 | -0.67 |
| Dec 31, 2021 | -1.22 |
| Sep 30, 2021 | -0.80 |